4Friends3YTyler

Threshold Pharmcaceuticals

Long
4Friends3YTyler Updated   
NASDAQ:THLD   None
THLD triggered my first level 1.29$ above the pennie mode. Main reason for it might be the release of phase III data from its clinical stage studies of Tarloxotinib. The data will be released somewhere in September. My next levels are 2.15$ and 2.75$.
Comment:
THLD release candidate failed. They wanna concentrate on clinical studies.... Unexpected downmove. But there seem to be some buyers left. I watch this by now.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.